Sales of Johnson & Johnson's pharmaceutical products 2015-2019

Johnson and Johnson is a major international pharmaceutical company. In 2019, among its top pharmaceutical drugs was Remicade which earned 4.38 billion U.S. dollars in sales for the company. Remicade is a drug used in the treatment of Crohn’s disease and ulcerative colitis. The highest revenue generating drug at that time was Stelara which generated 6.36 billion U.S. dollars in revenue for the company.

International pharmaceutical companies

There are several major pharmaceutical companies that are making significant economic impacts globally. As of 2018, Pfizer, Roche and Novartis were the top pharmaceutical companies based on their prescription drug sales globally. Despite being excluded from the top three list of pharmaceutical companies based on prescription drug sales, Johnson and Johnson is among the top four drug companies based on drug sales. However, when viewed by market capitalization, Johnson and Johnson, Novartis and Roche were the top three global companies.

Top pharmaceuticals

The global pharmaceutical industry has never generated as much revenue as it has in recent years. Globally, oncologics, antidiabetics and respiratory drug classes are the top three based on total sales. However, there are some drugs that are more widely distributed and sold globally. As of 2018, Humira from AbbVie, Eliquis from BMS/Pfizer and Revlimid by Celgene were the top drugs based on sales worldwide.